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The neuronal ceroid lipofuscinoses (NCLs), the most common neurodegenerative diseases in
children, are characterised by storage of autofluorescent material that has a characteristic
ultrastructure. We report two families with variant late infantile NCL, both originating from
Pakistan. Probands from both families were homozygous for the same mutation (c.316dupC)
buthadvariablepathology to thatcurrently thought tobe typical forCLN6disease, late infantile
variant. The observed pathology of one proband resembled condensed fingerprints, previously
described in late infantile CLN7 and CLN8 diseases, and pathology from the second proband
was thought to be absent even after repeated skin biopsy, but observed after review. This
mutation is themostcommonNCLmutation in familiesoriginating fromPakistanandcouldbe
prioritised for testing. Finally, this report contains the first prenatal diagnosis for late infantile
CLN6 disease, initially made on the basis of EM and now confirmed bymutation analysis.
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the remainder can be distinguished only by sequencing to
identify or exclude a disease-causing variation. However, the
ultrastructural pathology of the storagematerial is commonly
used to guide the order of sequential sequencing.4
We report two families, both originating from Pakistan, in
which the probands were homozygous for the samemutation
but had variable pathology to that currently thought to be
typical for CLN6 disease, late infantile variant.2. Case reports
2.1. Case 1 (UCL468)
The proband was born to parents who were first cousins orig-
inating from Pakistan. Normal development was observed
until his first seizure just before the age of 3 years after which
he became unsteady on his feet, and developed myoclonic
epilepsy. There was an 18month history of nystagmus, ataxia
and wide based gait, rough skin with increased pigment and a
decelerating head circumference. He presented with bilateral
optic atrophy and ERG deterioration by age 4. An EEG showed
general bursts of sharp and slow waves and brain MRI dis-
played deficient inferior vermis and large cysternamagna at 4
years; by 5 years the patient had deteriorated, with abnormal
myelination and ex-vacuo dilatation of ventricles thereby
suggesting an atrophic process. By this age he was blind, in a
wheelchair and unable to perform any skills. Later he became
bed-ridden, with gastrostomy, and was stiff and uncomfort-
ablewhenmoved.Hearingwas retained.Hediedaged11years.
Examination of blood films stained with May-Grundwald gi-
emsa showed no evidence of lymphocyte vacuolation. Rectal
biopsy and blood sampleswere examined comprehensively by
lightmicroscopy and subsequently, ultrastructural analysis by
transmission electron microscopy (EM). Submucosal ganglion
cells showed prominent storage granules and stained posi-
tively with periodic acid Schiff’s reaction, Luxol fast blue,
Sudan black. The storage material exhibited strong auto-
fluorescence when examined by ultraviolet light. The smooth
muscle cells of the muscularis layer also had autofluorescent
inclusions and stained positively for acid phosphatase. A
muscle biopsy showed large active acid phosphatase positive
lysosomes. Ultrastructural examination confirmed the pres-
ence of sparse storage deposits in lymphocytes. The storage
materialwasmembrane-boundas compact lipopigmentswith
fingerprint profiles and amorphous material, confirming NCL
disease (Fig. 1(a) and (b)). Variant late infantile NCL was diag-
nosed at age 5. CLN7 and CLN8 genes were excluded as the
cause of disease by sequencing.
Following diagnosis of NCL but prior to genetic confirma-
tion, there was a pregnancy terminated at 14 weeks due to the
presence of inclusions in chorionic villus sample (CVS)
(Fig. 1(c) and (d)), with inclusions confirmed in the aborted
foetus (Fig. 1(e)). These were amorphous and of low density. A
subsequent pregnancy for which CVS was normal resulted in
a healthy sister.
DNA from the proband was exome sequenced and whole
genome genotyped. Genomic DNA was prepared according to
Illumina’s TruSeq Sample preparation and Exome Enrichmentprotocols (Illumina, CA). Captured DNA was sequenced on an
Illumina HiSeq 2000 using 2100 bp paired-end reads.
Resulting sequences were aligned to the human genome
reference (hg19) and variants called using GATK.5 Variants
were annotated according to their presence in publicly avail-
able databases (1000Genomes and dbSNP build 135). The
initial filtering process excluded all synonymous and hetero-
zygous variants present in the proband. There were 57 ho-
mozygous variants, of which one was a pathogenic mutation
in CLN6 (NM_017882: c.316dupC: p.Arg106ProfsX26). Both
parents were carriers, and DNA from the aborted foetus was
homozygous for this same change.
2.2. Case 2 (UC593)
The proband is the only child of first degree consanguineous
parents from Rawalpindi in northern Pakistan. Early develop-
mentwasnormal.His speechandwalking began todeteriorate
when 3 years old. When 4 years he developed shaking of both
legswhich progressed tomyoclonic jerkswithin a year, and he
experienced his first generalised tonic clonic seizure at age 6,
his current age. He now has continuous wringing hand
movements, can no longer bearweight and has lost eating and
drinking skills. MRI showed cerebral and cerebellar atrophy
with ex-vacuodilationof lateral ventricles. Theperiventricular
white matter and posterior limb of internal capsules along
with deep cerebellar white matter showed high T2 signal with
hazy appearances. The optic nerve and chiasm were thinner
than normal. Flash electroretinogramswere absent bilaterally
with giant flash visual evoked responses. This was further
confirmed with abnormal somatosensory evoked potentials
(giant cortical response) and present C reflexes. Giant flash
visual responses were evoked at slow flash rate of 1.2 Oz-Fz.
NCL was suspected. However, ultrastructural examination
of a skin biopsy twice failed to reveal any inclusions. EM of
buffy coat was not requested. Nevertheless, DNA was sub-
mitted for sequencing of genes that typically cause NCL with
onset in late infancy and a known pathogenic mutation
(c.316dupC: p.Arg106ProfsX26) was found in homozygous
form in CLN6. Subsequent ultrastructural analysis re-
examination of the second skin biopsy by transmission elec-
tron microscopy showed distinct storage inclusions in sweat
gland epithelium, endothelial cells and smooth muscle cells
(Fig. 2). The storage was of a mixed type with curvilinear-like
and fingerprint profiles.
2.3. Ethical standards
All work was approved by UCL Research Ethics Committee.
The parents of the probands gave informed consent prior to
inclusion in this study and to its publication.3. Discussion
These two cases demonstrate important considerations
regarding pathology in CLN6 disease, and perhaps NCL in
general, since both are atypical. In family UCL468 the pa-
thology is more condensed than previously reported for late
infantile CLN6 disease, but resembles that reported for CLN7
Fig. 1 e UCL468 proband sample image of: (a) buffy coat lymphocyte with a discrete, membrane bound, lipopigment storage
inclusion and (b) high power image demonstrating the fingerprint profile of the storage material. UCL468 sibling foetus
chorionic villus sample image of: (c) subtrophoblastic blood vessel endothelial cell with three storage inclusions that are
amorphous, and of medium electron density with occasional stacks of lamellae, and (d) fibroblast with three membrane
bound inclusions. (e) High power image of inclusions with lamellae identified in various foetal tissues (14 weeks) including
the CNS.
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was detected to begin with in a skin biopsy which would
normally be taken to exclude NCL, however subsequent re-
examination of a second biopsy in a different laboratory did
reveal pathology that was typical for NCL but was different to
that in family UCL468. The pathology in other families car-
rying the same mutation has not previously been reported in
detail, but was mixed curvilinear and fingerprint profiles in
endothelial cells and smooth muscle cells of a skin biopsy in
families homozygous for the same mutations (UCL423 and
UCL233) and mixed curvilinear and fingerprint profiles in
conjunctival biopsy from a family heterozygous for the same
mutation (UCL202) (unpublished data). Thus, pathology for
the group of variant late infantile NCLs may vary and cannot
be reliably used as a guide to order of gene analysis. In addi-
tion, and importantly, NCL gene analysis should still be
considered in a child showing typical clinical symptoms even
if pathology has been reported as absent.There are now five Pakistani family described with this
mutation in CLN6,6 suggesting a founder mutation that is
predicted to introduce a premature stop codon. In one family
homozygous for the same mutation (UCL423) the mutant
protein was no longer detected by polyclonal antisera to
CLN6.7
Other Pakistani families diagnosed with NCL carry private
mutations in CLN5 (two mutations), CLN6 (one additional
mutation to that reported here), CLN8 (three mutations) and
CLN10 (two mutations), with none yet reported causing CLN1,
CLN2, CLN3, CLN4 or CLN7 diseases.2,8 Thus, it should be high
priority to test for this CLN6 mutation in Pakistani families
with any type of suspected NCL, but particularly with onset in
late infancy, regardless of ultrastructural pathology of storage
material, or even its apparent absence. Mutations in CLN6 are
now known to cause disease whose age of onset ranges from
late infancy to adult.9 This report demonstrates the power of
second generation sequencing technologies to very quickly
Fig. 2 e UCL 593 proband sample image of: (a) skin biopsy
showing sweat gland epithelial cells with storage material,
and (b) high power image demonstrating distinct storage
inclusions of mixed type (curvilinear-like and fingerprint
profiles).
e u r o p e a n j o u r n a l o f p a e d i a t r i c n e u r o l o g y 1 7 ( 2 0 1 3 ) 6 5 7e6 6 0660identify the causative gene in families which are atypical or
where the mostly likely candidate genes have been excluded.
Given the challenge experienced here of observing pathology
in a skin biopsy, electron microscopy on buffy coat could be
considered earlier in the diagnostic pathway.
In conclusion, NCL should be considered in children with a
consistent clinical picture and normal levels of PPT1, TPP1 or
CTSD, even in the absence of obvious inclusions on skin bi-
opsy, and a biopsy should be reviewed when the suspicion of
NCL remains high. The choice of gene testing should be
influenced more by the ethnic background of the affected
child than the pattern of ultrastructural deposits.
Finally, it is worth noting that this is the first report of
prenatal diagnosis for CLN6 disease late infantile variant,
initially made on the basis of electron microscopy (EM) and
now confirmed by mutation analysis. Caution should be used
in applying EM to prenatal diagnosis e direct detection of the
causative mutation(s) is preferable. Interestingly, in this onefamily, the inclusions detected in the CVS and confirmed in
the foetus did not have the fingerprint profile and condensed
nature of those in the proband but weremore amorphous and
of less density suggesting that these inclusions are in the very
early stages of formation.
Acknowledgements
We thank the families for facilitating this research, Sarah Ball
at BirminghamChildren’s Hospital, and Dr TonyMcShane and
Dr Vanda Joss at Churchill Hospital, Oxford. This work was
supported in part by the Wellcome Trust/MRC Joint Call in
Neurodegeneration award (WT089698) and the European
Union Seventh Framework Programme (FP7/2007-2013) under
grant agreement n 281234, the Medical Research Council
(core support at LMCB), and the Batten Disease Support and
Research Association, USA. Research at Great Ormond Street
NHS Trust benefits from R & D funding received from the NHS
Executive. Financial support from the Batten Disease and
Support Research Association USA is also acknowledged.r e f e r e n c e s
1. Williams RE, Mole SE. New nomenclature and classification
scheme for the neuronal ceroid lipofuscinoses. Neurology
2012;79:183e91.
2. Kousi M, Lehesjoki AE, Mole SE. Update of the mutation
spectrum and clinical correlations of over 360 mutations in
eight genes that underlie the neuronal ceroid lipofuscinoses.
Hum Mutat 2012;33:42e63.
3. Mole SE. Neuronal ceroid lipofuscinoses (NCL). Europ J Paediatr
Neurol 2006;10:255e7.
4. Mole SE, Williams RE, Goebel HH. The neuronal ceroid
lipofusinoses (Batten disease). In: Contemporary neurology.
Oxford: Oxford University Press; 2011. p. 444.
5. McKenna A, Hanna M, Banks E, et al. The Genome Analysis
Toolkit: a MapReduce framework for analyzing next-
generation DNA sequencing data. Genome Res
2010;20:1297e303.
6. Wheeler RB, Sharp JD, Schultz RA, et al. The gene mutated in
variant late infantile neuronal ceroid lipofuscinosis (CLN6) and
nclf mutant mice encodes a novel predicted transmembrane
protein. Am J Hum Genet 2002;70:537e42.
7. Mole SE, Michaux G, Codlin S, et al. CLN6, which is associated
with a lysosomal storage disease, is an endoplasmic reticulum
protein. Exp Cell Res 2004;298:399e406.
8. Noskova L, Stranecky V, Hartmannova H, et al. Mutations in
DNAJC5, encoding cysteine-string protein alpha, cause
autosomal-dominant adult-onset neuronal ceroid
lipofuscinosis. Am J Hum Genet 2011;89:241e52.
9. Arsov T, Smith KR, Damiano J, et al. Kufs disease, the major
adult form of neuronal ceroid lipofuscinosis, caused by
mutations in CLN6. Am J Hum Genet 2011;88:566e73.
